Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

More than 14 million children around the world have not received a single dose of any vaccine, according to new data from the World Health Organization and UNICEF.

Data released this week by the World Health Organization and UNICEF indicate modest gains in childhood vaccination rates, but ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

A new global report from the World Health Organization (WHO) Commission on Social Connection reveals that one in six people ...

An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...

A draft pandemic treaty negotiated at the World Health Organisation (WHO) leaves health policy to national governments, ...